Evolus Stock

Evolus Equity

The The Equity of Evolus (EOLS) as of Aug 8, 2026 is -23.11 M USD. In the previous year, The Equity was 5.52 M USD — a change of -518.44% (lower).

Equity

-23.11 MUSD

YoY

-518.44%

Last updated:

In 2026, Evolus's equity was -23.11 M USD, a -518.44% increase from the 5.52 M USD equity in the previous year.

Access this data via the Eulerpool API

Evolus Stock analysis

What does Evolus do? Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Evolus's Equity

Evolus's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Evolus's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Evolus's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Evolus's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Evolus’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Evolus stock

The Equity of Evolus is -23.11 M USD in 2026.

The Equity of Evolus changed from 5.52 M USD to -23.11 M USD, representing a -518.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Evolus since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Evolus historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Evolus

All Key Metrics — Evolus